Two founders of JHL Biotech have recently been indicted for conspiracy to steal trade secrets from the Californian company, while two other individuals pleaded guilty to similar charges
A tie-up would have boosted the company’s portfolio in key areas, but past deals and organic growth have already created a strong foundation in the space
Recent recordals show the electric car maker has cut a deal with Panasonic, assimilated a large portfolio of solar rights and gained assets via M&A deals Read more
After letter from Senators Leahy and Tillis telling President Biden to pick up the pace of appointments, Hill source tells IAM that IP needs to be seen as a tier one priority Read more
After seeing her work recognised by the IPO, the company's assistant chief IP counsel Sandra Nowak spoke with IAM on why some parts of the market are still playing catch-up Read more
Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP Read more
White House confirms widely expected u-turn on US governmemt approach to FRAND-related issues in a move that will have little domestic impact but could be a big deal internationally Read more
Company president Joe Siino tells IAM the pool operator has secured virtually all the key innovators behind MPEG-H to roll out a unified licensing solution Read more
Lina Khan’s appointment as FTC chair puts a vocal critic of Silicon Valley’s titans at the heart of policy-making, but also raises big IP questions Read more
White House confirms widely expected u-turn on US governmemt approach to FRAND-related issues in a move that will have little domestic impact but could be a big deal internationally Read more
White House confirms widely expected u-turn on US governmemt approach to FRAND-related issues in a move that will have little domestic impact but could be a big deal internationally Read more
Second quarter panels report finds a marked increase in negative views about the administration, but fewer covid concerns and signs of higher royalty and sales prices Read more
That both the Xperi subsidiary and the defensive aggregator were involved in bidding for MobiTV’s assets shows the growing importance of the content delivery space to dealmakers Read more
Technologist and VC funder Alex Eleftheriadis warns that VVC is on a slippery slope to the same kind of fractured licensing landscape as HEVC Read more
US cases brought by PanOptis and Sisvel were dismissed earlier this month, adding to evidence that auto company might have signed up to wireless pool Read more
White House confirms widely expected u-turn on US governmemt approach to FRAND-related issues in a move that will have little domestic impact but could be a big deal internationally Read more
In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court. Read more
Saturday Opinion: American IP owners would be better served by a DOJ focus on bringing home blockbuster trade secrets cases regardless of nationality Read more
The opportunity to shut out competitors after a 30-day investigation would be a powerful tool for businesses, but potentially a very dangerous one too Read more
Second quarter panels report finds a marked increase in negative views about the administration, but fewer covid concerns and signs of higher royalty and sales prices Read more
Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP Read more
Company president Joe Siino tells IAM the pool operator has secured virtually all the key innovators behind MPEG-H to roll out a unified licensing solution Read more
Globalisation in the 5G era has reduced the clout of portfolios centred on the country, but decisions taken by the government, the courts and in boardrooms have hastened the process Read more
